-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U2aKukRC3COlDffQA1WKU7do2PwuPNjSbYIfxSP2q8NGIx6ZD0SQwdRsyE1znpHh oi4LlJsR834OgOan86Q9LQ== 0001286774-10-000001.txt : 20100407 0001286774-10-000001.hdr.sgml : 20100407 20100407150349 ACCESSION NUMBER: 0001286774-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100407 DATE AS OF CHANGE: 20100407 EFFECTIVENESS DATE: 20100407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONDINE BIOPHARMA Corp CENTRAL INDEX KEY: 0001286774 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-64540 FILM NUMBER: 10736905 BUSINESS ADDRESS: STREET 1: 910-1100 MELVILLE ST CITY: VANCOUVER STATE: A1 ZIP: V6E4A6 BUSINESS PHONE: 604-669-0555 MAIL ADDRESS: STREET 1: 910-1100 MELVILLE ST CITY: VANCOUVER STATE: A1 ZIP: V6E4A6 FORMER COMPANY: FORMER CONFORMED NAME: ONDINE BIOPHARMA CORP DATE OF NAME CHANGE: 20040412 D 1 primary_doc.xml X0603 D LIVE 0001286774 ONDINE BIOPHARMA Corp 910-1100 MELVILLE ST VANCOUVER A1 V6E4A6 604-669-0555 BRITISH COLUMBIA, CANADA ONDINE BIOPHARMA CORP Corporation true William Harper 910-1100 Melville Street Vancouver A1 V6E 4A6 Executive Officer Nicholas Loebel 910-1100 Melville Street Vancouver A1 V6E 4A6 Executive Officer Thomas Dawson 910-1100 Melville Street Vancouver A1 V6E 4A6 Executive Officer Merrill Biel 910-1100 Melville Street Vancouver A1 V6E 4A6 Director Terence Holland 910-1100 Melville Street Vancouver A1 V6E 4A6 Director Margaret Shaw 910-1100 Melville Street Vancouver A1 V6E 4A6 Director Colin Watt 910-1100 Melville Street Vancouver A1 V6E 4A6 Director Michael Crane 910-1100 Melville Street Vancouver A1 V6E 4A6 Director Carolyn Cross 910-1100 Melvilee Street Vancouver A1 V6E 4A6 Executive Officer Director Biotechnology $1 - $1,000,000 06 false 2010-04-05 false true true true private sale of units see also Item 13 for more information. false 0 45463 45463 0 Amount is US$ value of 760,0000 units issued at C$0.06 each, each unit consists of one common share and one warrant to purchase one common share for C$0.075 until Apr 5/11. Bank of CAD daily noon ex. rate is 1CAD=0.9970 US dollars on Apr 7, 10. false 3 0 0 0 false ONDINE BIOPHARMA Corp William S. Harper William S. Harper Chief Financial Officer and Corporate Secretary 2010-04-07 -----END PRIVACY-ENHANCED MESSAGE-----